Comment on [LINK] Open Source Software Developer with Terminal Illness Hopes to Opt Out of Death

Wed, 13 Feb 2013 20:34:29 GMT

For one, Hextend, a blood plasma volume expander used in conventional surgery, was developed by cryonicists at Trans Time, Inc while experimenting with hypothermia.

Can you provide more information, please?

The product you mention seems to have been developed by BioTime, a biomedical company.
The only relationship between BioTime and Trans Time (a now defunct for-profit cryonics company) that I've been able to find on Google was that Trans Time owned some stocks of BioTime:

http://www.cryonet.org/cgi-bin/dsp.cgi?msg=6399

Discuss